Global Equine Veterinary Therapeutics Supply, Demand and Key Producers, 2023-2029

Global Equine Veterinary Therapeutics Supply, Demand and Key Producers, 2023-2029

The global Equine Veterinary Therapeutics market size is expected to reach $ 2012.5 million by 2029, rising at a market growth of 6.5% CAGR during the forecast period (2023-2029).

A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.

Equine Veterinary Therapeutics refers to the specialized field of veterinary medicine that focuses on the diagnosis, treatment, and management of health issues and injuries in horses. This branch of veterinary science encompasses a wide range of therapeutic interventions, including medical, surgical, and rehabilitative approaches, all aimed at maintaining the health, well-being, and performance of equines. Equine veterinary therapeutics play a crucial role in ensuring the overall health and longevity of horses, whether they are involved in sports and competition or serve as companion animals.

This report studies the global Equine Veterinary Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Equine Veterinary Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Equine Veterinary Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Equine Veterinary Therapeutics total market, 2018-2029, (USD Million)

Global Equine Veterinary Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Equine Veterinary Therapeutics total market, key domestic companies and share, (USD Million)

Global Equine Veterinary Therapeutics revenue by player and market share 2018-2023, (USD Million)

Global Equine Veterinary Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)

Global Equine Veterinary Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Equine Veterinary Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Merck Animal Health, Zoetis, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine and Kyoritsu Seiyaku, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Equine Veterinary Therapeutics market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Equine Veterinary Therapeutics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Equine Veterinary Therapeutics Market, Segmentation by Type
Drugs
Vaccine
Other

Global Equine Veterinary Therapeutics Market, Segmentation by Application
Veterinary Hospital
Veterinary Clinics
Other

Companies Profiled:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard

Key Questions Answered

1. How big is the global Equine Veterinary Therapeutics market?

2. What is the demand of the global Equine Veterinary Therapeutics market?

3. What is the year over year growth of the global Equine Veterinary Therapeutics market?

4. What is the total value of the global Equine Veterinary Therapeutics market?

5. Who are the major players in the global Equine Veterinary Therapeutics market?